Example: Heart Attack

Search clinical trials for: Acarbose

Total 82 results

NCT01245166

Unknown status

A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus

Conditions: The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg, Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in, Subjects With Type 2 Diabetes Mellitus.
NCT02865499

Completed

Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)

Conditions: Aging
NCT02589353

Recruiting

Human Oral Detection of Glucose Olygomers

Conditions: Healthy Volunteers
NCT00846521

Terminated

Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity

Conditions: Pediatric Obesity, Insulin Resistance, Impaired Glucose Tolerance, Cardiovascular Disease
NCT00858676

Unknown status

Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)

Conditions: Diabetes Mellitus, Impaired Glucose Tolerance, Coronary Artery Disease
NCT00677521

Terminated

A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)

Conditions: Non-alcoholic Fatty Liver Disease
NCT00558883

Completed

AI(I)DA Acarbose and the Subclinical Inflammation

Conditions: Type 2 Diabetes Mellitus, Subclinical Inflammation
NCT00221156

Completed

Acarbose and Secondary Prevention After Coronary Stenting

Conditions: Glucose Metabolism Disorders, Coronary Artery Disease
NCT00417950

Unknown status

Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes

Conditions: Diabetes Mellitus, Impaired Glucose Tolerance
NCT00417729

Completed

Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DM

Conditions: Diabetes Mellitus
NCT01244971

Completed

Exercise and Acarbose in Type 2 Diabetes

Conditions: Diabetes Mellitus Type 2
NCT01000688

Completed

Vildagliptin and Endothelium-dependent Vasodilatation

Conditions: Type 2 Diabetes, Endothelial Dysfunction
NCT01316861

Completed

Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT01490918

Completed

Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients

Conditions: Type 2 Diabetes Mellitus
NCT03344341

Terminated

A Phase IV Study in Drug-Naive Patients With T2DM in China

Conditions: Type 2 Diabetes Mellitus
NCT02500329

Unknown status

Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients

Conditions: Endothelial Function, Type 2 Diabetes, Gemigliptin, Acarbose
NCT02355509

Completed

Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients

Conditions: Glucose Intolerance, Postprandial Hyperglycemia, Cardiovascular Risk Factor
NCT02315495

Completed

Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes

Conditions: Type 2 Diabetes
NCT04180813

Recruiting

Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

Conditions: Diabetes Mellitus, Type 2
NCT02999841

Unknown status

Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients

Conditions: Diabetes Mellitus, Type 2, Obesity
NCT02953093

Completed

Study of Acarbose in Longevity

Conditions: Aging
NCT00629213

Completed

Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial

Conditions: Metabolic Syndrome
NCT03602638

Unknown status

Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

Conditions: Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1
NCT02043886

Completed

Acarbose, Postprandial Hypotension and Type 2 Diabetes

Conditions: Type 2 Diabetes, Postprandial Hypotension
NCT02243176

Completed

24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy

Conditions: Type 2 Diabetes Mellitus